DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Persistent Atrial FibrillationAtrial Fibrillation
Interventions
DEVICE

Radiofrequency Ablation

A procedure will be performed using a radiofrequency ablation catheter.

Trial Locations (28)

10029

Icahn School of Medicine at Mount Sinai, New York

10467

Montefiore Medical Center, New York

14021

Institut Klinicke a Experimentalni Mediciny (IKEM), Prague

15000

Na Homolce, Prague

20138

Centro Cardiologico Monzino, Milan

29406

Trident Medical Center, Charleston

29425

Medical University Of South Carolina, Charleston

30174

Ospedale dell'Angelo, Venezia

31076

Clinique Pasteur, Toulouse

32751

Advent Health, Florida Hospital Orlando, Orlando

35242

Grandview Medical Center, Birmingham

35294

University Of Alabama, Birmingham

38801

North Mississippi Medical Center, Tupelo

39216

Jackson Heart Clinic, Jackson

50266

Iowa Heart Center, West Des Moines

54511

CHRU Nancy, Nancy

65691

St Ann's University Hospital, Brno

66000

Clinique Saint Pierre, Perpignan

66211

Kansas City Heart Rhythm Institute, Overland Park

69100

Clinique du Tonkin, Villeurbanne

77030

Houston Methodist Hospital, Houston

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

90033

Keck School Of Medicine, Los Angeles

02114

Massachusetts General Hospital, Boston

L3Y2P6

Southlake Regional Health Center, Newmarket

HITC8

Montreal Heart Institute, Montreal

G1V4G5

Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Québec

04289

Leipzig Heart Institute GmbH, Leipzig

All Listed Sponsors
lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT03643224 - DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter